Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

3,010 public trials 644 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

NCT00003091

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

Bloomington Hospital Bloomington, Indiana, United States

Baptist Regional Cancer Center - Knoxville Knoxville, Tennessee, United States

St. Joseph Regional Cancer Center Bryan, Texas, United States

View Trial Details

Completed

Dolastatin 10 in Treating Patients With Advanced Kidney Cancer

NCT00003914

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic Jacksonville Jacksonville, Florida, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Biological Therapy in Treating Patients With Metastatic Cancer

NCT00002733

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +25 more
Locations: Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

View Trial Details

Completed

Prognostic Factor for Renal Cell Carcinoma (RCC) With Venous Tumor Thrombus

NCT01328691

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +18 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

Interferon Alfa (IFN-Alpha-1b) in Renal Cancer With Metastatic Kidney Cancer

NCT00278174

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer

NCT00186277

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients

NCT00859768

Conditions: Bladder Cancer, Breast Cancer, Breast Diseases, +56 more
Locations: Institute Verbeeten Tilburg, North Brabant, Netherlands

View Trial Details

Completed

Combined Use of BCG and Interferon Alpha in Bladder Cancer

NCT00330707

Conditions: Carcinoma, Carcinoma of Urinary Bladder, Superficial, Female Urogenital Diseases, +13 more
Locations: National University Hospital Singapore

View Trial Details

Completed

A Phase II Study of AZD4877 (a Novel Anti-mitotic Agent) in Advanced Bladder Cancer

NCT00661609

Conditions: Bladder Cancer, Disease Attributes, Female Urogenital Diseases, +21 more
Locations: Research Site Palo Alto, California, United States

Research Site San Bernardino, California, United States

Research Site Southington, Connecticut, United States

Research Site Miami, Florida, United States

View all 36 locations

View Trial Details

Completed

Detection of Chromosomal Aberrations in Urine Samples Using Fluorescent in Situ Hybridization (FISH) (UroVysion Test)

NCT01264744

Conditions: Bladder Cancers, Chromosome Aberrations, Female Urogenital Diseases, +12 more
Locations: VA Hospital Los Angeles, California, United States

PLUS Diagnostics Union, New Jersey, United States

Sheila Dobin, Ph.D. Temple, Texas, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions